MedTrace Logo

Vitamin C and Hiprex in rUTI

NCT06710899 · Status: NOT_YET_RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2026-02-11

No results posted yet for this study

Summary

A single centre proof of concept study to assess whether Vitamin C improves the efficacy of Methenamine Hippurate (Hiprex®) in the prophylaxis of recurrent urinary tract infections (rUTIs) in women

Conditions

Interventions

DRUG

Methenamine Hippurate 1g BD

Methenamine Hippurate 1g BD for 6 months

DRUG

Methenamine Hippurate 1g BD + Vitamin C 1g BD

Methenamine Hippurate 1g BD + Vitamin C 1g BD for 6 months

Sponsors & Collaborators

  • University Hospitals of North Midlands NHS Trust

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2027-01-31
Primary Completion
2027-08-31
Completion
2028-01-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06710899 on ClinicalTrials.gov